Functions and mechanisms of RNA m6A regulators in breast cancer (Review)
International Journal of Oncology · 2024
DOI: 10.3892/ijo.2024.5674 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2024. Verfasst von Yibei Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou…. Hauptthemen laut MEDLINE: Breast Neoplasms, Adenosine, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Breast cancer (BC) is a major malignant tumor in females and the incidence rate of BC has increased worldwide in recent years. N6‑methyladenosine (m6A) is a methylation modification that occurs extensively in eukaryotic RNA. The abnormal expression of m6A and related regulatory proteins can activate or inhibit certain signal pathways or oncogenes, thus affecting the proliferation, metastasis and prognosis of BC. Numerous studies have shown that m6A regulator disorder exists in BC, and this disorder can be reversed. Therefore, m6A is predicted as a potential therapeutic target for BC. However, the molecular mechanism of m6A RNA methylation regulating the occurrence and development of BC has not been comprehensively elucidated. In this review article, the functions of various m6A regulators and the specific mechanisms of certain regulators of the progress of BC were summarized. Furthermore, the dual role of RNA methylation in tumor progression was discussed, concluding that RNA methylation can not only lead to tumorigenesis but at times give rise to inhibition of tumor formation. In addition, further comprehensive analysis on mechanisms of m6A regulators in BC is conducive to screening effective potential targets and formulating targeted treatment strategies, which will provide new methods for the prevention and treatment of BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Westlake University School of…
- Department of Urology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang 310000, P.R. China.
- Fourth Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310051, P.R. China.
Zitieren
APA
Yang, Y., Gao, F., Ren, L., Ren, N., Pan, J., & Xu, Q. (2024). Functions and mechanisms of RNA m6A regulators in breast cancer (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2024.5674
Vancouver
Yang Y, Gao F, Ren L, Ren N, Pan J, Xu Q. Functions and mechanisms of RNA m6A regulators in breast cancer (Review). International Journal of Oncology. 2024. doi:10.3892/ijo.2024.5674
BibTeX
@article{Yang2024,
author = {Yang, Yibei and Gao, Feng and Ren, Lanqi and Ren, Ning and Pan, Junjie and Xu, Qiaoping},
title = {Functions and mechanisms of RNA m6A regulators in breast cancer (Review)},
journal = {International Journal of Oncology},
year = {2024},
doi = {10.3892/ijo.2024.5674}
}
EUVIMED